The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy

BACKGROUND: Schlafen 11 (SLFN11) was recently identified as a dominant determinant of sensitivity to DNA-targeting agents including platinum-based drugs. SLFN11 also reportedly enhances cellular radiosensitivity. In this study, we examined the prognostic value of SLFN11 expression in esophageal squa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagami, Takuma, Yamade, Mihoko, Suzuki, Takahiro, Uotani, Takahiro, Tani, Shinya, Hamaya, Yasushi, Iwaizumi, Moriya, Osawa, Satoshi, Sugimoto, Ken, Miyajima, Hiroaki, Baba, Satoshi, Sugimura, Haruhiko, Murai, Junko, Pommier, Yves, Furuta, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678160/
https://www.ncbi.nlm.nih.gov/pubmed/33218331
http://dx.doi.org/10.1186/s12885-020-07574-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678160/
https://www.ncbi.nlm.nih.gov/pubmed/33218331
http://dx.doi.org/10.1186/s12885-020-07574-x

Ejemplares similares